User login
Primary tabs
Concerned about African Swine Fever? Newport Labs does not use any raw materials from countries identified by the USDA as potential carriers of foreign animal diseases, including China.
UPGRADE YOUR TOOLBOX
Discover an easier way to manage isolates with this exclusive software tool tailored to veterinarians.
Use HerdPoint™ for easier isolate management and a more efficient nonadjacent approval process.
Filling in the Gaps with Custom-Made Vaccines
There are economic costs associated with some key bovine diseases.
Custom-made vaccines can help protect your herd from these diseases and reduce your economic losses.
Press Releases
Pinkeye: New Challenges Call for New Solutions
Cattle herds exposed to infectious bovine keratoconjunctivitis, more commonly known as pinkeye, are at risk of lower calf-growth rate, potential blindness and permanent damage if left untreated.1 It’s estimated that pinkeye causes annual losses of more than $150 million in the United States, affecting over 10 million calves.1
With an emerging species of pinkeye bacteria overtaking the previously predominant species, controlling this increasingly complex disease is challenging for many producers and veterinarians. But there are tools that can help.
3 Key Advancements in the Fight Against Strep
As producers continue to reduce the amount of antibiotics given to their herds, many are looking to other options to fight Streptococcus suis, more commonly known as Strep suis.
The pathogen is one of the primary causes of bacterial meningitis in pigs,1 and can cause illness at any stage of production, with associated mortality rates of up to 20 percent.2 With infections often existing subclinically and nearly 100 percent of pigs serving as carriers of the bacteria,3Strep suis is a key concern for many producers.
New Software Streamlines Custom-Vaccine Management for Livestock Veterinarians
WORTHINGTON, Minn. (Sept. 4, 2018) — Newport Laboratories, Inc., a leader in livestock custom-made vaccines (CMVs), today launches HerdPoint,™ a new solution for veterinarians that streamlines the nonadjacent-herd approval process and ongoing isolate management, all from a mobile phone or computer.
Newport Laboratories is now part of Boehringer Ingelheim
DULUTH, Ga. — [June 12, 2018]
Boehringer Ingelheim (BI) is excited to announce that Newport Laboratories, Inc. in Worthington, Minnesota, is officially part of Boehringer Ingelheim’s animal health business unit.
Newport Laboratories enhances the service and product offerings for BI customers. By providing cutting-edge diagnostics like whole genome sequencing, metagenomics, and bioinformatics, Newport Laboratories crafts custom, autogenous vaccines that target the specific viruses or bacteria causing disease in individual livestock operations.
A New Era of